David Shapiro, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 2,000 shares at $106.62 ($213K) on 2018-12-17, disclosed to the SEC on 2018-12-19.
Open-market sale of $213k ICPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |